SlideShare a Scribd company logo
2015 - Achievements and challenges
Harry Rothenfluh, PhD
Assistant Secretary
Manufacturing Quality Branch
Overview
• 2015: Achievements and challenges
• GMP clearances
• Inspections performance data
• Looking ahead to 2016
• Inspection close out process improvement
• Rewarding consistent high levels of compliance
2
GMP clearances
3
GMP clearance applications
To 23 October
3900 3941
4222
5873
1929
0
1000
2000
3000
4000
5000
6000
7000
11/12 12/13 13/14 14/15 15/16
4
What are we doing to reduce clearance times?
Improving our ability to meet demand
• OMQ restructure: aligning structure with function
• Improved application triaging
• Improved information management
Communication
• Updates on TGA website
• PDA presentations!
• TGA - Industry Working Group on Manufacturing Quality
5
GMP clearance processing times - median
08-19
June
22-03
June-July
06-17 July 20-31 July
03-14
August
17-28
August
31-11
August-
September
14-25
September
28-09
September
-October
12-23
October
Median 18.80 14.14 9.86 9.43 7.00 5.43 8.07 3.86 4.14 4.86
Number of Applications 153 257 161 182 183 170 106 111 94 101
0
50
100
150
200
250
300
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
16.00
18.00
20.00
(weeks)
Medianweekstocompletion
6
GMP clearance processing times - average
08-19
June
22-03
June-July
06-17 July 20-31 July
03-14
August
17-28
August
31-11
August-
September
14-25
September
28-09
September
-October
12-23
October
Average 17.71 14.92 11.93 12.25 9.99 8.81 11.32 6.16 5.42 10.55
Number of Applications 153 257 161 182 183 170 106 111 94 101
0
50
100
150
200
250
300
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
16.00
18.00
20.00
AverageWeeksTo
Completion
7
Inspections
8
What’s in store for 2016?
Helping sponsors understand their role
• GMP clearance application tool
• GMP clearance guideline revision
Reducing impact of poor quality applications
• Decisions will be made based on information provided by the
sponsor in the application
9
Inspection performance
2014 - 15
• 92% of domestic initial inspections conducted within target timelines (3 months)
2015 - 16 to end October
• 94% of domestic reinspections (44/47) conducted within target timelines (6
months)
10
What’s in store for 2016?
Revised inspection close out process
• Objective:
o Predictable inspection close out times for manufacturers who comply with
requirements
• How:
o No objective evidence required if acceptable CAPAs
o Next inspection will include assessment of CAPAs
o Limited rounds of additional information requests
11
What’s in store for 2016?
Rewarding consistent high levels of compliance.
• Objective:
o Reduced regulatory burden for manufacturers with repeat A1 rating
• How:
o 3 year reinspection frequency for A1 manufacturers of high risk products
(currently 2 years)
o Second and subsequent A1 ratings: reduced scope inspection
12
Questions?
13

More Related Content

What's hot

Presentaion: Updates to Good Manufacturing Practices
Presentaion: Updates to Good Manufacturing PracticesPresentaion: Updates to Good Manufacturing Practices
Presentaion: Updates to Good Manufacturing Practices
TGA Australia
 
Presentation: What’s new in the 2019 RMP guidance update?
Presentation: What’s new in the 2019 RMP guidance update?Presentation: What’s new in the 2019 RMP guidance update?
Presentation: What’s new in the 2019 RMP guidance update?
TGA Australia
 
Who good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproductsWho good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproducts
adeelzia84
 
TGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updatesTGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updates
TGA Australia
 
PSM Interchange 2014: Marv Shepherd, United State Pharmacopeia Good Distribut...
PSM Interchange 2014: Marv Shepherd, United State Pharmacopeia Good Distribut...PSM Interchange 2014: Marv Shepherd, United State Pharmacopeia Good Distribut...
PSM Interchange 2014: Marv Shepherd, United State Pharmacopeia Good Distribut...
The Partnership For Safe Medicines
 
PIC/S Guide to GMP PE009-13 - Key changes to Annex 15 - Qualification and val...
PIC/S Guide to GMP PE009-13 - Key changes to Annex 15 - Qualification and val...PIC/S Guide to GMP PE009-13 - Key changes to Annex 15 - Qualification and val...
PIC/S Guide to GMP PE009-13 - Key changes to Annex 15 - Qualification and val...
TGA Australia
 
Presentation: The ACSS Consortium and the Generic Medicines Work-Sharing Trial
Presentation: The ACSS Consortium and the Generic Medicines Work-Sharing TrialPresentation: The ACSS Consortium and the Generic Medicines Work-Sharing Trial
Presentation: The ACSS Consortium and the Generic Medicines Work-Sharing Trial
TGA Australia
 
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc  scientific-regulatory affairs-qms and c gmp consult...Sai pharma solutions inc  scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
JRamniwas
 
Using the new OTC guidance to help compile a successful application
Using the new OTC guidance to help compile a successful applicationUsing the new OTC guidance to help compile a successful application
Using the new OTC guidance to help compile a successful application
TGA Australia
 
Tga presentation Regulatory Reforms at the Therapeutic - Goods Administratio...
Tga presentation Regulatory Reforms at the Therapeutic  -	Goods Administratio...Tga presentation Regulatory Reforms at the Therapeutic  -	Goods Administratio...
Tga presentation Regulatory Reforms at the Therapeutic - Goods Administratio...
TGA Australia
 
Eu and usa key differences 1
Eu and usa key differences 1Eu and usa key differences 1
Eu and usa key differences 1
Ann McGee
 
Therapeutic Innovation Australia Symposium 2017 - SME Assist
Therapeutic Innovation Australia Symposium 2017 - SME AssistTherapeutic Innovation Australia Symposium 2017 - SME Assist
Therapeutic Innovation Australia Symposium 2017 - SME Assist
TGA Australia
 
Presentation: Prescription medicine registration process performance
Presentation: Prescription medicine registration process performancePresentation: Prescription medicine registration process performance
Presentation: Prescription medicine registration process performance
TGA Australia
 
TGA presentation: The role of the TGA
TGA presentation: The role of the TGATGA presentation: The role of the TGA
TGA presentation: The role of the TGA
TGA Australia
 
Good manufacturing practices for complementary medicines
Good manufacturing practices for complementary medicinesGood manufacturing practices for complementary medicines
Good manufacturing practices for complementary medicines
TGA Australia
 
TGA’s role in ensuring quality complementary medicines
TGA’s role in ensuring quality complementary medicinesTGA’s role in ensuring quality complementary medicines
TGA’s role in ensuring quality complementary medicines
TGA Australia
 
Presentation: A journey to better medicine labels - an update on TGO 92
Presentation: A journey to better medicine labels - an update on TGO 92Presentation: A journey to better medicine labels - an update on TGO 92
Presentation: A journey to better medicine labels - an update on TGO 92
TGA Australia
 
Notifications to prescription medicines
Notifications to prescription medicinesNotifications to prescription medicines
Notifications to prescription medicines
TGA Australia
 
Adoption of TGO 91 - Prescription medicine labelling
Adoption of TGO 91 - Prescription medicine labelling Adoption of TGO 91 - Prescription medicine labelling
Adoption of TGO 91 - Prescription medicine labelling
TGA Australia
 
Regulatory affairs.
Regulatory affairs.Regulatory affairs.
Regulatory affairs.
Naila Kanwal
 

What's hot (20)

Presentaion: Updates to Good Manufacturing Practices
Presentaion: Updates to Good Manufacturing PracticesPresentaion: Updates to Good Manufacturing Practices
Presentaion: Updates to Good Manufacturing Practices
 
Presentation: What’s new in the 2019 RMP guidance update?
Presentation: What’s new in the 2019 RMP guidance update?Presentation: What’s new in the 2019 RMP guidance update?
Presentation: What’s new in the 2019 RMP guidance update?
 
Who good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproductsWho good distributionpracticesforpharmaceuticalproducts
Who good distributionpracticesforpharmaceuticalproducts
 
TGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updatesTGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updates
 
PSM Interchange 2014: Marv Shepherd, United State Pharmacopeia Good Distribut...
PSM Interchange 2014: Marv Shepherd, United State Pharmacopeia Good Distribut...PSM Interchange 2014: Marv Shepherd, United State Pharmacopeia Good Distribut...
PSM Interchange 2014: Marv Shepherd, United State Pharmacopeia Good Distribut...
 
PIC/S Guide to GMP PE009-13 - Key changes to Annex 15 - Qualification and val...
PIC/S Guide to GMP PE009-13 - Key changes to Annex 15 - Qualification and val...PIC/S Guide to GMP PE009-13 - Key changes to Annex 15 - Qualification and val...
PIC/S Guide to GMP PE009-13 - Key changes to Annex 15 - Qualification and val...
 
Presentation: The ACSS Consortium and the Generic Medicines Work-Sharing Trial
Presentation: The ACSS Consortium and the Generic Medicines Work-Sharing TrialPresentation: The ACSS Consortium and the Generic Medicines Work-Sharing Trial
Presentation: The ACSS Consortium and the Generic Medicines Work-Sharing Trial
 
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc  scientific-regulatory affairs-qms and c gmp consult...Sai pharma solutions inc  scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
 
Using the new OTC guidance to help compile a successful application
Using the new OTC guidance to help compile a successful applicationUsing the new OTC guidance to help compile a successful application
Using the new OTC guidance to help compile a successful application
 
Tga presentation Regulatory Reforms at the Therapeutic - Goods Administratio...
Tga presentation Regulatory Reforms at the Therapeutic  -	Goods Administratio...Tga presentation Regulatory Reforms at the Therapeutic  -	Goods Administratio...
Tga presentation Regulatory Reforms at the Therapeutic - Goods Administratio...
 
Eu and usa key differences 1
Eu and usa key differences 1Eu and usa key differences 1
Eu and usa key differences 1
 
Therapeutic Innovation Australia Symposium 2017 - SME Assist
Therapeutic Innovation Australia Symposium 2017 - SME AssistTherapeutic Innovation Australia Symposium 2017 - SME Assist
Therapeutic Innovation Australia Symposium 2017 - SME Assist
 
Presentation: Prescription medicine registration process performance
Presentation: Prescription medicine registration process performancePresentation: Prescription medicine registration process performance
Presentation: Prescription medicine registration process performance
 
TGA presentation: The role of the TGA
TGA presentation: The role of the TGATGA presentation: The role of the TGA
TGA presentation: The role of the TGA
 
Good manufacturing practices for complementary medicines
Good manufacturing practices for complementary medicinesGood manufacturing practices for complementary medicines
Good manufacturing practices for complementary medicines
 
TGA’s role in ensuring quality complementary medicines
TGA’s role in ensuring quality complementary medicinesTGA’s role in ensuring quality complementary medicines
TGA’s role in ensuring quality complementary medicines
 
Presentation: A journey to better medicine labels - an update on TGO 92
Presentation: A journey to better medicine labels - an update on TGO 92Presentation: A journey to better medicine labels - an update on TGO 92
Presentation: A journey to better medicine labels - an update on TGO 92
 
Notifications to prescription medicines
Notifications to prescription medicinesNotifications to prescription medicines
Notifications to prescription medicines
 
Adoption of TGO 91 - Prescription medicine labelling
Adoption of TGO 91 - Prescription medicine labelling Adoption of TGO 91 - Prescription medicine labelling
Adoption of TGO 91 - Prescription medicine labelling
 
Regulatory affairs.
Regulatory affairs.Regulatory affairs.
Regulatory affairs.
 

Similar to Manufacturing Quality Branch – 2015 Achievements and Challenges

TGA Presentation: GMP Clearance Information Session,5-7 September 2017
TGA Presentation: GMP Clearance Information Session,5-7 September 2017TGA Presentation: GMP Clearance Information Session,5-7 September 2017
TGA Presentation: GMP Clearance Information Session,5-7 September 2017
TGA Australia
 
CINET Middle-East Best Practice Workshop
CINET Middle-East Best Practice Workshop CINET Middle-East Best Practice Workshop
CINET Middle-East Best Practice Workshop
Cinet_PTC
 
Quality Metrics Program - Impact & Challenges
Quality Metrics Program - Impact & ChallengesQuality Metrics Program - Impact & Challenges
Quality Metrics Program - Impact & Challenges
pi
 
Current inspection trends
Current inspection trendsCurrent inspection trends
Current inspection trends
TGA Australia
 
Qms & iatf presentation1
Qms & iatf presentation1Qms & iatf presentation1
Qms & iatf presentation1
Krishna Kant Pandey
 
quality-metrics-1.pdf
quality-metrics-1.pdfquality-metrics-1.pdf
quality-metrics-1.pdf
reza684755
 
OTC Business Process Review - achievements and opportunities
OTC Business Process Review - achievements and opportunitiesOTC Business Process Review - achievements and opportunities
OTC Business Process Review - achievements and opportunities
TGA Australia
 
Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...
Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...
Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...
Greenlight Guru
 
Training Prog :: Vendor quality Management system-Vendor development
Training Prog :: Vendor quality Management system-Vendor developmentTraining Prog :: Vendor quality Management system-Vendor development
Training Prog :: Vendor quality Management system-Vendor development
Varmahk
 
Lean Operation Strategy--Nov. 12
Lean Operation Strategy--Nov. 12Lean Operation Strategy--Nov. 12
Lean Operation Strategy--Nov. 12Bill Yan
 
IATF 16949:2016 Clause Modification & Add
IATF 16949:2016 Clause Modification & AddIATF 16949:2016 Clause Modification & Add
IATF 16949:2016 Clause Modification & Add
Neerav Poothia (Urgently need a Change)
 
Iso final
Iso finalIso final
Latest trends in manufacturing quality
Latest trends in manufacturing qualityLatest trends in manufacturing quality
Latest trends in manufacturing quality
TGA Australia
 
SSCG Automotive Manufacturing Quality Management
SSCG Automotive Manufacturing Quality ManagementSSCG Automotive Manufacturing Quality Management
SSCG Automotive Manufacturing Quality Management
SSCG Consulting
 
Peregrine's Quality Presentation
Peregrine's Quality PresentationPeregrine's Quality Presentation
Peregrine's Quality Presentation
RFSOI
 
TS 16949 ASQ Presentation.ppt
TS 16949 ASQ Presentation.pptTS 16949 ASQ Presentation.ppt
TS 16949 ASQ Presentation.ppt
RakeshKumarSSDISO
 
Quality Metrics- Dr.A. Amsavel.pptx
Quality Metrics- Dr.A. Amsavel.pptxQuality Metrics- Dr.A. Amsavel.pptx
Quality Metrics- Dr.A. Amsavel.pptx
Dr. Amsavel A
 

Similar to Manufacturing Quality Branch – 2015 Achievements and Challenges (20)

TGA Presentation: GMP Clearance Information Session,5-7 September 2017
TGA Presentation: GMP Clearance Information Session,5-7 September 2017TGA Presentation: GMP Clearance Information Session,5-7 September 2017
TGA Presentation: GMP Clearance Information Session,5-7 September 2017
 
CINET Middle-East Best Practice Workshop
CINET Middle-East Best Practice Workshop CINET Middle-East Best Practice Workshop
CINET Middle-East Best Practice Workshop
 
Quality Metrics Program - Impact & Challenges
Quality Metrics Program - Impact & ChallengesQuality Metrics Program - Impact & Challenges
Quality Metrics Program - Impact & Challenges
 
Current inspection trends
Current inspection trendsCurrent inspection trends
Current inspection trends
 
Qms & iatf presentation1
Qms & iatf presentation1Qms & iatf presentation1
Qms & iatf presentation1
 
quality-metrics-1.pdf
quality-metrics-1.pdfquality-metrics-1.pdf
quality-metrics-1.pdf
 
OTC Business Process Review - achievements and opportunities
OTC Business Process Review - achievements and opportunitiesOTC Business Process Review - achievements and opportunities
OTC Business Process Review - achievements and opportunities
 
Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...
Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...
Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...
 
Training Prog :: Vendor quality Management system-Vendor development
Training Prog :: Vendor quality Management system-Vendor developmentTraining Prog :: Vendor quality Management system-Vendor development
Training Prog :: Vendor quality Management system-Vendor development
 
Renni Consultancy - Introduction
Renni Consultancy - IntroductionRenni Consultancy - Introduction
Renni Consultancy - Introduction
 
Asq presentationkjkj
Asq presentationkjkjAsq presentationkjkj
Asq presentationkjkj
 
Asq presentation
Asq presentationAsq presentation
Asq presentation
 
Lean Operation Strategy--Nov. 12
Lean Operation Strategy--Nov. 12Lean Operation Strategy--Nov. 12
Lean Operation Strategy--Nov. 12
 
IATF 16949:2016 Clause Modification & Add
IATF 16949:2016 Clause Modification & AddIATF 16949:2016 Clause Modification & Add
IATF 16949:2016 Clause Modification & Add
 
Iso final
Iso finalIso final
Iso final
 
Latest trends in manufacturing quality
Latest trends in manufacturing qualityLatest trends in manufacturing quality
Latest trends in manufacturing quality
 
SSCG Automotive Manufacturing Quality Management
SSCG Automotive Manufacturing Quality ManagementSSCG Automotive Manufacturing Quality Management
SSCG Automotive Manufacturing Quality Management
 
Peregrine's Quality Presentation
Peregrine's Quality PresentationPeregrine's Quality Presentation
Peregrine's Quality Presentation
 
TS 16949 ASQ Presentation.ppt
TS 16949 ASQ Presentation.pptTS 16949 ASQ Presentation.ppt
TS 16949 ASQ Presentation.ppt
 
Quality Metrics- Dr.A. Amsavel.pptx
Quality Metrics- Dr.A. Amsavel.pptxQuality Metrics- Dr.A. Amsavel.pptx
Quality Metrics- Dr.A. Amsavel.pptx
 

More from TGA Australia

Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
TGA Australia
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
TGA Australia
 
Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch
TGA Australia
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI template
TGA Australia
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
TGA Australia
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future state
TGA Australia
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...
TGA Australia
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
TGA Australia
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
TGA Australia
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
TGA Australia
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
TGA Australia
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine Shortages
TGA Australia
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
TGA Australia
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2
TGA Australia
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory maze
TGA Australia
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA Australia
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
TGA Australia
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
TGA Australia
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Australia
 
Presentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & APresentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & A
TGA Australia
 

More from TGA Australia (20)

Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
 
Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI template
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future state
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine Shortages
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory maze
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
 
Presentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & APresentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & A
 

Recently uploaded

HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 

Recently uploaded (20)

HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 

Manufacturing Quality Branch – 2015 Achievements and Challenges

  • 1. 2015 - Achievements and challenges Harry Rothenfluh, PhD Assistant Secretary Manufacturing Quality Branch
  • 2. Overview • 2015: Achievements and challenges • GMP clearances • Inspections performance data • Looking ahead to 2016 • Inspection close out process improvement • Rewarding consistent high levels of compliance 2
  • 4. GMP clearance applications To 23 October 3900 3941 4222 5873 1929 0 1000 2000 3000 4000 5000 6000 7000 11/12 12/13 13/14 14/15 15/16 4
  • 5. What are we doing to reduce clearance times? Improving our ability to meet demand • OMQ restructure: aligning structure with function • Improved application triaging • Improved information management Communication • Updates on TGA website • PDA presentations! • TGA - Industry Working Group on Manufacturing Quality 5
  • 6. GMP clearance processing times - median 08-19 June 22-03 June-July 06-17 July 20-31 July 03-14 August 17-28 August 31-11 August- September 14-25 September 28-09 September -October 12-23 October Median 18.80 14.14 9.86 9.43 7.00 5.43 8.07 3.86 4.14 4.86 Number of Applications 153 257 161 182 183 170 106 111 94 101 0 50 100 150 200 250 300 0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 (weeks) Medianweekstocompletion 6
  • 7. GMP clearance processing times - average 08-19 June 22-03 June-July 06-17 July 20-31 July 03-14 August 17-28 August 31-11 August- September 14-25 September 28-09 September -October 12-23 October Average 17.71 14.92 11.93 12.25 9.99 8.81 11.32 6.16 5.42 10.55 Number of Applications 153 257 161 182 183 170 106 111 94 101 0 50 100 150 200 250 300 0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 AverageWeeksTo Completion 7
  • 9. What’s in store for 2016? Helping sponsors understand their role • GMP clearance application tool • GMP clearance guideline revision Reducing impact of poor quality applications • Decisions will be made based on information provided by the sponsor in the application 9
  • 10. Inspection performance 2014 - 15 • 92% of domestic initial inspections conducted within target timelines (3 months) 2015 - 16 to end October • 94% of domestic reinspections (44/47) conducted within target timelines (6 months) 10
  • 11. What’s in store for 2016? Revised inspection close out process • Objective: o Predictable inspection close out times for manufacturers who comply with requirements • How: o No objective evidence required if acceptable CAPAs o Next inspection will include assessment of CAPAs o Limited rounds of additional information requests 11
  • 12. What’s in store for 2016? Rewarding consistent high levels of compliance. • Objective: o Reduced regulatory burden for manufacturers with repeat A1 rating • How: o 3 year reinspection frequency for A1 manufacturers of high risk products (currently 2 years) o Second and subsequent A1 ratings: reduced scope inspection 12